
Martin P. Dybek
Financial Analyst
Stock Analysis on Net
If you are a successful investor, you are able to take advantage of stock exchange potential for extraordinary profit, you always buy undervalued companies cheap and sell them expensive after their price has risen, you don’t need to go inside. You will certainly not be interested in Stock Analysis on Net.
Today, try for free:
Eli Lilly & Co.
Financial statements analysis and stock valuation
Dividend Discount Model (DDM)
The Dividend Discount Model (DDM) is a technique for estimating the value of a share of Eli Lilly & Co.’s common stock issue as the present value of all future dividends.
Return on Equity (ROE)
since 2005
Eli Lilly & Co.’s profitability ratio calculated as net income divided by shareholders’ equity.
Profitability Analysis
Quarterly Data
Measures the income of Eli Lilly & Co. relative to its revenues and invested capital.
Statement of Financial Position, Assets
Quarterly Data
The assets reports major classes and amounts of resources owned or controlled by Eli Lilly & Co..
Selected Financial Data
since 2005
Main items of Eli Lilly & Co.’s financial statements.
Common-Size Statement of Financial Position, Assets
Assets components shown as percentage of total assets.
What’s new
Friday, February 15, 2019
PepsiCo Inc. (PEP) annual report
for fiscal year ended December 29, 2018
Friday, February 15, 2019
Illinois Tool Works Inc. (ITW) annual report
for fiscal year ended December 31, 2018
Friday, February 15, 2019
Allergan PLC (AGN) annual report
for fiscal year ended December 31, 2018
Thursday, February 14, 2019
Caterpillar Inc. (CAT) annual report
for fiscal year ended December 31, 2018
Wednesday, February 13, 2019
Amgen Inc. (AMGN) annual report
for fiscal year ended December 31, 2018
Wednesday, February 13, 2019
Raytheon Co. (RTN) annual report
for fiscal year ended December 31, 2018